Dee Hopkins
Aged care policies proving a major barrier for patients
Blanket policies in aged-care facilities, including complete lockdowns and two-week quarantines for residents who seek external medical treatment, have been ...
Tackling treatment adherence in AMD
As part of Macula Month this May, Insight explores why treatment adherence remains such a major challenge for some patients ...
Novartis secures approval for AMD drug in Australia
Australia’s ophthalmic community has welcomed the approval of Novartis’ latest therapy for neovascular age-related macular degeneration (nAMD). Advocates hope the ...